Scholarlink

<p>Machine Learning (ML) and Artificial Intelligence (AI) approaches have potential to make better-informed decisions in chemical hazard identification while reducing animal testing. Their application in the context of New Approach Methodologies (NAMs) for Hazard Identification in Chemicals Risk Assessment (CRA) is challenging due to the limited knowledge, lack of experience, and uncertainty related to the use of these approaches. Therefore, to facilitate ML and AI approaches' potential acceptance for regulatory use, better standardization, guidelines for transparent reporting, validation, and frameworks are needed to understand their accessibility, verifiability, and usefulness criteria for predictions. An extensive literature review on the availability of ML and AI based NAMs for chemical hazard identification was conducted, focusing primarily on human health endpoints: specific target organ toxicity (STOT), genotoxicity and carcinogenicity, endocrine disruption, skin sensitization, developmental and reproductive toxicity (DART), and repeated dose or chronic toxicity. Nearly 2300 scientific articles were reviewed, and 274 publications with ML-QSAR models revealed that 60.9% of the models described in the scientific literature turned out to be non-usable, 21.9% were potentially usable, and 17.2% were directly usable, i.e., had available software solutions. By endpoint, the skin sensitization is best covered with the ML-QSAR models, followed by endocrine disruption, genotoxicity, and carcinogenicity models. The most derived ML-QSAR models are tree-based models such as random forests, and analogues, followed by artificial neural networks and support vector machine models, with other models being used to a lesser extent. The literature analysis led to a framework that helps model users to identify potentially suitable models for use in a regulatory context. In addition, the framework could help model developers better understand the expectations of model users in a regulatory context and use the framework as a reference when publishing their models, ensuring greater transparency, alignment with regulatory needs, and facilitating future acceptance.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Perspective on applicability of data-driven machine learning computational new approach methodologies for hazard identification in chemicals risk assessment

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月26日

查看全文
  • Geven Piir,
  • Sulev Sild,
  • Olga Tcheremenskaia,
  • Emma Di Consiglio,
  • Jörgen Henriksson,
  • Agnieszka Gajewicz-Skretna,
  • Enrico Mombelli,
  • Alessandra Roncaglioni,
  • Uko Maran

摘要

Machine Learning (ML) and Artificial Intelligence (AI) approaches have potential to make better-informed decisions in chemical hazard identification while reducing animal testing. Their application in the context of New Approach Methodologies (NAMs) for Hazard Identification in Chemicals Risk Assessment (CRA) is challenging due to the limited knowledge, lack of experience, and uncertainty related to the use of these approaches. Therefore, to facilitate ML and AI approaches' potential acceptance for regulatory use, better standardization, guidelines for transparent reporting, validation, and frameworks are needed to understand their accessibility, verifiability, and usefulness criteria for predictions. An extensive literature review on the availability of ML and AI based NAMs for chemical hazard identification was conducted, focusing primarily on human health endpoints: specific target organ toxicity (STOT), genotoxicity and carcinogenicity, endocrine disruption, skin sensitization, developmental and reproductive toxicity (DART), and repeated dose or chronic toxicity. Nearly 2300 scientific articles were reviewed, and 274 publications with ML-QSAR models revealed that 60.9% of the models described in the scientific literature turned out to be non-usable, 21.9% were potentially usable, and 17.2% were directly usable, i.e., had available software solutions. By endpoint, the skin sensitization is best covered with the ML-QSAR models, followed by endocrine disruption, genotoxicity, and carcinogenicity models. The most derived ML-QSAR models are tree-based models such as random forests, and analogues, followed by artificial neural networks and support vector machine models, with other models being used to a lesser extent. The literature analysis led to a framework that helps model users to identify potentially suitable models for use in a regulatory context. In addition, the framework could help model developers better understand the expectations of model users in a regulatory context and use the framework as a reference when publishing their models, ensuring greater transparency, alignment with regulatory needs, and facilitating future acceptance.